Paradigm Biopharmaceuticals Ltd reported AUD147.19M in Ordinary Share Capital for its first fiscal semester of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Ordinary Share Capital Change
Opthea Ltd OPT:AU USD 235.28M 87.92M
Pacific Edge PEB:NZ NZD 294.14M 26.44M
PYC Therapeutics Ltd PYC:AU AUD 125.99M 0
Telix Pharmaceuticals Ltd TLX:AU AUD 344.11M 173.27M